Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedA notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.SummaryDifference1%

- Check19 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected study details, indicating an access or server issue that prevents viewing the entry.SummaryDifference19%

- Check68 days agoChange DetectedThe page now displays a new revision number (v3.6.6) replacing the previous v3.6.5, indicating a backend software update rather than a content change.SummaryDifference0.1%

Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.